PATENT CLAIM ANALYSIS

Application Number: 15946943
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "017200"]

Abstract:
Methods and compositions for modulating JNK activity and stimulating efferocytosis in a cell or patient are described. Therapeutic modified collagens comprising a plurality of proteins characterized by Table 1 for use as JNK modulators are also described.

Claim (Index 20):
A method of stimulating efferocytosis comprising, administering to a subject in need thereof a therapeutically effective amount of a JNK modulator according to  claim 19 .

Metadata:
- Claim Count in Document: 17.0
- Percentile: 91.0
- Lexical Diversity: 1.21875
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15540661', '15880490', '15110108', '14775667', '13809876']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7313901901274822
- 35 USC 102 Novelty (BERT): 0.538534736029499
- Combined Prediction Score: 0.7121046447176839
- Mean Citation Score: 236.3933
- Max Citation Score: 383.2831
- Similarity Product: 249.63528079206944

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test